Ispaghula husk, plantago seed, sennoside b

Sold as Agiolax

No structure available

This product's active ingredient could not be matched to a single known compound.

Loading Wikipedia summary

Registration

Applicants: 1
Registrations: 1

Applicants and registrations

Applicant	Brands	Dosages	Registrations	Schedule	Leaflets
Shanur Healthcare (Pty) LtdCertificate held by Xixia Pharmaceuticals (Pty) Ltd	Agiolax	5g	E0988	Not determined	PI PIL

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Agiolax EACH 5,0 g GRANULES CONTAINS: ISPAGHULA HUSK 0,11 g, PLANTAGO SEED 2,6 g, SENNA POD EQUIVALENT TO SENNOSIDE B 15,0 mg	5gGranules	E0988E/11.5/0988Approved 3 May 2022	Registered	Not determined	PI PIL

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Professional information (PI)For healthcare professionalsAgiolax, Shanur Healthcare (Pty) Ltd Patient information leaflet (PIL)For patients and carersAgiolax, Shanur Healthcare (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading PubMed articles

Background